Mouse ES cells can differentiate into all three germ layers of the embryo but are generally excluded from the trophoblast lineage. Here we show that ES cells deficient in DNA methylation can differentiate efficiently into trophoblast derivatives. In a genome-wide screen we identified the transcription factor Elf5 as methylated and repressed in ES cells, and hypomethylated and expressed in TS and methylation-deficient ES cells. Elf5 creates a positive-feedback loop with the TS cell determinants Cdx2 and Eomes that is restricted to the trophoblast lineage by epigenetic regulation of Elf5. Importantly, the late-acting function of Elf5 allows initial plasticity and regulation in the early blastocyst. Thus, Elf5 functions as a gatekeeper, downstream of initial lineage determination, to reinforce commitment to the trophoblast lineage or to abort this pathway in epiblast cells. This epigenetic restriction of cell lineage fate provides a molecular mechanism for Waddington's concept of canalization of developmental pathways.
Mouse ES cells can differentiate into all three germ layers of the embryo but are generally excluded from the trophoblast lineage. Here we show that ES cells deficient in DNA methylation can differentiate efficiently into trophoblast derivatives. In a genome-wide screen we identified the transcription factor Elf5 as methylated and repressed in ES cells, and hypomethylated and expressed in TS and methylation-deficient ES cells. Elf5 creates a positive-feedback loop with the TS cell determinants Cdx2 and Eomes that is restricted to the trophoblast lineage by epigenetic regulation of Elf5. Importantly, the late-acting function of Elf5 allows initial plasticity and regulation in the early blastocyst. Thus, Elf5 functions as a gatekeeper, downstream of initial lineage determination, to reinforce commitment to the trophoblast lineage or to abort this pathway in epiblast cells. This epigenetic restriction of cell lineage fate provides a molecular mechanism for Waddington's concept of canalization of developmental pathways.
Formation of the first two cell populations of the blastocyst, the trophectoderm (TE) and the inner cell mass (ICM), represents the earliest differentiation event in mammalian development. TE cells are restricted in their differentiation potential to the trophoblast lineage, which is essential for formation of the placenta. By contrast, cells of the ICM lose their capacity to differentiate into trophoblast derivatives, but remain pluripotent and give rise to all cell types of the embryo proper, as well as to extra-embryonic endoderm and mesoderm [1] [2] [3] [4] . Embryonic stem (ES) cells are derived from the ICM of blastocyst-stage embryos 5 . Similarly to ICM cells, they are extremely efficient in colonizing all germ layers of the embryo 6 , but are generally excluded from the trophoblast lineage 7 . Conversely, trophoblast stem (TS) cells, derived from the TE, differentiate into all trophoblast subtypes of the placenta, but are excluded from embryonic tissues 8, 9 . Thus, the stem-cell populations derived from the blastocyst stably retain the cell lineage restrictions that are imposed by this stage.
The initial cell lineage specification is established by key transcription factors, such as Oct4, Nanog and Sox2, as well as Cdx2 and Eomes, which are capable of defining embryonic and trophoblast lineage identity, respectively 10 . Once fixed, lineage determination must be accompanied by epigenetic modifications that ensure the stable inheritance of cell fate 11 . It is particularly important to determine how lineage-specific transcription factor networks interact with different epigenetic marking systems to achieve this stability. One of the earliest global epigenetic marks that distinguishes the ICM and TE lineages is DNA methylation: ICM cells become de novo methylated in early blastocysts, whereas TE cells remain hypomethylated 12 . This global difference in methylation between embryonic and extra-embryonic tissues is maintained throughout development 13, 14 . Expression of few markers of differentiated trophoblast has been observed in embryoid bodies derived from Dnmt-deficient (and therefore hypomethylated) ES cells 15 , indicating a functional role of this differential methylation pattern. Here, we have examined in detail the role of DNA methylation in the stability of embryonic lineage determination. We show that ES cells and cells of the embryo proper that are deficient in methylation can differentiate into trophoblast derivatives, progressing in an orderly fashion from stem cells towards giant cells. DNA methylation-mediated silencing of a trophoblastspecific transcription factor, Elf5, normally restricts this differentiation pathway. The identification of this epigenetically regulated gatekeeper provides an explanation for the early, definitive nature of embryonic and trophoblast cell lineage separation.
RESULTS

Trophoblast from Dnmt1
-/-embryonic cells To evaluate whether DNA methylation is essential for the stability of embryonic cell lineage determination, we examined whether trophoblast differentiation occurs from ES cells deficient in DNA methylation caused by deletion of the maintenance DNA methyltransferase, Dnmt1. Formation of trophoblast giant cells, a morphologically distinct placental cell type, was observed only sporadically when Dnmt1 -/-ES cells were grown in standard ES cell medium. In contrast, about 25% of all Dnmt1 -/-ES cells differentiated into trophoblast giant cells when cultured under TS cell conditions, as assessed by morphological criteria and by marker gene expression (Fig. 1a, b) . In a time-course experiment in which Dnmt1 -/-ES cells were subjected to TS cell conditions for 2-12 days, the trophoblast 
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Eomes Tpbpa Pl1 Pl2 -/-conceptuses only. Higher magnification views show the morphology of these cells; they are larger than surrounding cells but do not reach the size of parietal trophoblast giant cells (shown in inset). Scale bar represents 100 µm (a).
stem-cell markers Eomes and Cdx2 were the first to be detected, followed by ectoplacental cone and spongiotrophoblast markers Ascl2 and Tpbpa and subsequently, giant-cell-expressed genes Pl1 (Prl3d1) and Pl2 (Prl3b1; Fig. 1b ). This sequence of expression is comparable to that observed when TS cells undergo differentiation 8 . No significant trophoblast differentiation or marker expression was observed with wild-type ES cells grown under TS cell conditions. Trophoblast differentiation was not restricted to methylation-deficient ES cells, but also occurred in Dnmt1 -/-embryos -/-ES cells grown for 6 days in TS cell conditions for Oct4 (Pou5f1), Nanog and Cdx2. Trophoblast differentiation was not triggered by downregulation of Oct4. Arrows point to cells expressing high amounts of both Cdx2 and Oct4. A more reciprocal expression pattern was observed for Nanog and Cdx2. Scale bars represent 100 µm (c) and 25 µm (d).
in vivo. Quantitative RT-PCR analysis showed a striking upregulation of markers for intermediate diploid trophoblast (Ascl2, Tpbpa) and trophoblast giant cells (Pl1, Pl2) in E9.5 Dnmt1-deficient embryos (Fig. 1c) , thus reflecting a mid-to-late stage in the time course of trophoblast transdifferentiation from embryonic cells. The spatial distribution and morphology of these ectopically differentiating trophoblast cells was determined by in situ hybridization where cells positive for Tpbpa, Plf (Prl2c2) and Pl1 were detected in Dnmt1 -/-but not wild-type embryos, with giant cell marker-expressing cells showing an enlarged cell size when compared with surrounding embryonic cells (Fig. 1d, e ). These data demonstrate the ectopic differentiation of trophoblast derivatives in Dnmt1-depleted embryos and ES cells, showing that appropriate DNA methylation levels are crucial for maintenance of the embryonic lineage.
The major difference between ES and TS cell culture conditions is the absence of leukaemia inhibitory factor (LIF) and the presence of FGF4 in TS cell medium. Therefore, we investigated whether the FGF signalling receptor in TS cells, Fgfr2c 8, 16, 17 , was expressed concomitantly with trophoblast differentiation. Like Cdx2, Fgfr2c was activated in Dnmt1 -/-but not wild-type ES cells when grown in TS cell medium. Importantly, wild-type ES cells could be induced to express trophoblast genes at levels similar to those observed in Dnmt1 -/-ES cells by addition of the methylation inhibitor 5-azacytidine (Fig. 2a, b) . As in Dnmt1 -/-ES cells, activation of trophoblast markers coincided with the appearance of giant cells (Fig. 2c) . Azacytidine treatment of Dnmt1 -/-ES cells did not lead to a further increase in TS-cellspecific Cdx2 and Fgfr2c expression, but instead caused upregulation of markers of differentiated trophoblast (Fig. 2b) , suggesting critical methylation threshold levels for trophoblast stem-cell maintenance.
We next asked whether trophoblast differentiation was triggered by downregulation of Oct4, as loss of Oct4 expression in ES cells leads to transdifferentiation into trophoblasts 18 . Even after six days of culture in TS cell medium, most cells co-expressed Cdx2 and Oct4 (Fig. 2d) . This pattern suggests that demethylation of ES cells has expanded their developmental plasticity to include both extra-embryonic and embryonic fate, rather than switching fate to one that is exclusively extra-embryonic. It may also reflect the pattern in compacting morulae in which Oct4 levels remain high in both Cdx2 + and Cdx2 -cells 19 . A more reciprocal pattern was observed with Cdx2 and Nanog (Fig. 2d) .
To correlate the temporal progression and spatial distribution of transdifferentiating trophoblast derivatives in situ, Dnmt1
-/-ES cells were co-stained for Cdx2 and Plf 2-6 days after culture in TS cell medium. Cdx2-positive cells were enlarged, compared with surrounding ES cells and typically emerged at the margins of ES cell colonies (Fig. 3a, i) . At the earliest time-points of giant cell differentiation, all Plf-positive giant cells were located directly adjacent or in very close spatial proximity to Cdx2-positive cell groups (Fig. 3a , ii). In addition, some cells were observed in a transition state of differentiation, staining weakly positive for both Cdx2 and Plf (Fig. 3a, iii) . The non-random appearance of giant cells indicates a clonal origin of trophoblast derivatives in Dnmt1 -/-ES cells and suggests that they recapitulate a differentiation pathway comparable to that of the trophoblast lineage proper (Fig. 3a) .
Dnmt1
-/-ES cells contribute to the TE As hypomethylation caused loss of embryonic lineage restriction in embryos and ES cells, we examined whether Dnmt1 -/-ES cells could directly contribute to the TE in aggregation chimaeras. For this experiment, histone H2B-GFP labelled Dnmt1 +/+ and Dnmt1 -/-ES cells were 'pre-conditioned' for transdifferentiation by culture in TS cell medium for 1-3 days before aggregation with 8-cell embryos. Comparable to original studies 7 , control ES cells contributed extremely rarely to the TE.
-/-ES cells, however, were observed in the TE of two-thirds of all blastocysts and showed a 5-fold increase in the contribution to the TE, compared with their wild-type counterparts (Fig. 3b ).
Elf5 is differentially methylated
Our finding that DNA methylation prevents trophoblast differentiation in ES cells and embryos suggests that cell lineage stability is achieved by methylating trophoblast determinants in the embryonic lineage. Hence, we analysed key determinants of the trophoblast lineage for promoter methylation in ES cells. Although Cdx2, Eomes and Fgfr2 were induced in differentiating Dnmt1
-/-ES cells, we found that these genes were unmethylated in both ES and TS cells ( Supplementary Information, Fig. S1 ). We thus carried out a genome-wide screen for promoter methylation by methylated DNA immunoprecipitation (meDIP) array hybridization 20 , comparing ES cells with TS cells. We screened for promoters that showed higher methylation levels in ES cells when compared with TS cells. A very small number of candidate promoters of this type were identified (see Methods); however, after validation by Sequenom mass array technology, only one gene, Elf5, with a robust difference in methylation was confirmed ( Fig. 4a; Supplementary Information, Fig. S2 ). Elf5 encodes a transcription factor of the Ets family, which has a pivotal role in the trophoblast lineage 21 . Upon ablation of Elf5, the TE lineage can be specified and blastocysts implant into the uterus, but the proliferative capacity of trophoblast stem cells is not maintained and conceptuses die shortly after implantation due to a lack of extra-embryonic ectoderm 21 . Detailed characterization of the Elf5 promoter methylation profile by bisulphite sequencing analysis revealed that the vast majority of CpG residues in the 1-kb upstream region were methylated in ES cells but unmethylated in TS cells (Fig. 4b) . Importantly, Dnmt1-deficient ES cells showed hypomethylation of the Elf5 promoter when compared with wild-type ES cells, especially closer to the transcriptional start site. This methylation pattern was stable, as it did not change over a 10-day time course of culture in TS cell conditions ( Supplementary Information, Fig. S2 ). The mosaic methylation pattern of Elf5 in Dnmt1 -/-ES cells may explain why not all, but typically a total of 40-60% of all Dnmt1 -/-cells were found to undergo transdifferentiation into trophoblast derivatives (that is, stem, intermediate, spongio-and giant trophoblast cells) during this time period.
Elf5 marks diploid trophoblast
Consistent with the trophoblast-specific expression of Elf5 in early mouse embryos 21 , Elf5 was detected in undifferentiated TS cells but was absent from ES cells (Fig. 5a, b) . Upon differentiation of TS cells, Elf5 expression was markedly downregulated (Fig. 5b) . Elf5 staining mostly overlapped with the TS cell marker Cdx2, but was also observed in some additional diploid trophoblast cells that were Cdx2-negative (Fig. 5c) . Analysis of the temporal regulation in vivo showed that Elf5 expression was initiated later than Cdx2. In contrast to Cdx2, only small amounts of Elf5 transcripts and no protein were detected in blastocysts (data not shown). However, Elf5 was readily detected in blastocyst outgrowths where a central core of Cdx2 + cells was overlaid by Cdx2 + and Elf5 + double-positive and then Cdx2-negative, Elf5-positive diploid, proliferative trophoblasts (Fig. 5d) . Similarly, Elf5 marked the extra-embryonic ectoderm of conceptuses immediately after implantation from E5.5 onwards (Fig. 5e ). These data show that Cdx2 precedes Elf5 expression in the emerging TE, but that Elf5 expression is sustained longer in diploid proliferating trophoblast of the extra-embryonic ectoderm (Fig. 5f ).
Elf5 activates Cdx2 and Eomes
To analyse whether hypomethylation of the Elf5 promoter correlates with its expression in cells of the embryonic lineage, we first assessed Dnmt1 -/-embryos and ES cells for ectopic activation of Elf5 and found that they expressed high levels of this transcription factor. In fact, Elf5 was the earliest and most significantly induced trophoblast marker in the time course of ES-to-trophoblast transdifferentiation, and was expressed in derivatives of every single cell ( Fig. 6a-c; Supplementary Information,  Fig. S4 ). Elf5 was also strongly activated when wild-type ES cells were treated with 5-azacytidine ( Supplementary Information, Fig. S4 ). To further test the direct relationship between hypomethylation and expression of Elf5 and the activation of trophoblast markers, we examined other hypomethylated ES cell models null for Np95, Dnmt3a/b or Cxxc1 [22] [23] [24] . In all three cell lines, the Elf5 promoter was hypomethylated, resulting in high expression of Elf5 and upregulation of other trophoblast markers ( Supplementary Information, Fig. S3 ). Thus, Elf5 expression is associated with loss of embryonic cell lineage determination, irrespective of how promoter demethylation is achieved. Consistent with the observations of Cdx2 and Oct4 co-expression shown above, activation of Elf5 at the earliest stages in the transdifferentiation cascade was independent of Oct4 repression (Fig. 6d) .
If expression of hypomethylated Elf5 was responsible for trophoblast differentiation from embryonic cells, Elf5 may directly activate the TS cell determinants Cdx2 and Eomes. Indeed both the Cdx2 and Eomes promoters contain the core binding motif for the transcription factor Elf5 (ref. 25) . Consistent with this hypothesis, we found that forced expression of Elf5 in wild-type ES cells resulted in a strong induction of Eomes as early as 24 h after transfection. Similarly, Cdx2 expression was significantly (>3-fold) activated after 24 h but peaked after 2-3 days of transfection with Elf5 (Fig. 6e) . We confirmed that Elf5 was able to activate the Cdx2 and Eomes promoters in co-transfection experiments of Elf5 with reporter constructs, and that conversely, Cdx2 (and probably Eomes) could also activate the Elf5 promoter ( Fig. 6f; Supplementary Information, Fig. S3 ). Chromatin immunoprecipitation (ChIP) assays showed that Elf5 interacted directly with the Cdx2 and Eomes promoters and that this interaction occurred exclusively in TS and Dnmt1 -/-ES cells, but not in wild-type ES cells ( Fig. 6g) . Hence, ectopic expression of Elf5 directly induces TS cell determinants and thereby initiates the trophoblast differentiation cascade in cells of the embryonic lineage. This differentiation pathway depends on Elf5, as trophoblast marker activation was significantly decreased in hypomethylated ES cells in which Elf5 expression was diminished (Fig. 7a) .
These data establish that Elf5 is essential to reinforce the expression of crucial TS cell factors, and provides an explanation for the observed loss of Cdx2 expression in Elf5-mutant conceptuses 21 . As indicated by the immunostaining patterns of blastocyst outgrowths and early conceptuses, however, this transcriptional activator function of Elf5 is limited to a relatively narrow spatiotemporal window, as Elf5 expression was sustained in diploid trophoblast cells that had ceased to express Cdx2 (Fig. 5) resulted in the widespread differentiation of cells with trophoblast (giant) cell morphology, but did not allow the establishment of self-renewing TS cell lines (Fig. 7b, c; Supplementary Information, Fig. S4 ). Thus, Elf5 creates a cell-lineage-restricting niche at the critical interface between promotion and loss of the self-renewing capacity of TS cells.
DISCUSSION
In this study we have made three significant observations. First, ES cells deficient in DNA methylation can differentiate efficiently into the trophoblast lineage. We showed that the trophoblast differentiation program occurs in vivo as well as in vitro and involves expression of TS cell transcription factors Cdx2, Eomes and Elf5, and progression in an orderly fashion from stem cells and intermediate trophoblasts to giant cells. Second, the transcription factor Elf5 binds to and positively regulates the Cdx2 and Eomes promoters, establishing a positive-feedback loop, which is crucial for maintenance of the TS cell population. Third, the Elf5 gene is hypomethylated in the trophoblast lineage, so that the feedback loop is sustained and leads to expansion of the stem-cell compartment and subsequent differentiation. By contrast, Elf5 is stably repressed by DNA methylation in the embryonic lineage; as a result any induction of trophoblast cell fate mediated by stochastic expression of Cdx2 or Eomes cannot be sustained in this compartment.
Several studies have demonstrated that epigenetic regulation through Polycomb group proteins is essential for maintenance of the pluripotent state within the embryonic lineage in ES cells [26] [27] [28] . Here, we show that DNA methylation functions as a lineage barrier between the embryonic and trophoblast lineage compartments (Fig. 7d) . Consequently, hypomethylated ES cells can adopt a trophoblast cell fate. It is important to note, however, that methylation-deficient ES cells have not simply switched from an ES to a trophoblast fate, but have broadened their potency to include both an embryonic and extra-embryonic fate. Thus, they adopt a state comparable to an earlier developmental stage before lineage commitment. This interpretation is consistent with the observed overlapping staining patterns of lineage markers. Although methylationdeficient ES cells are able to express the trophoblast determinants Cdx2 and Eomes (as well as Fgfr2), the promoters of these genes are not methylated in wild-type ES cells. Therefore, we performed a genome-wide screen for promoter methylation differences between ES and TS cells. This analysis revealed that the global methylation asymmetry observed between the embryonic and trophoblast lineage is not reflected by the methylation profile of gene promoters on a large scale. The major differences in methylation between the two lineages are therefore likely to be located in non-genic regions, such as centromeric heterochromatin. These observations are similar to those of the X chromosome where global hypermethylation but promoter-specific hypomethylation occurs on the active X 29 . However, by specifically screening for gene promoters with higher methylation levels in ES cells, we identified Elf5 as the gatekeeper gene that is methylated in ES cells but unmethylated in TS cells. Elf5 is activated through Fgf-Fgfr signalling 30 and in turn activates Eomes and Cdx2. When the Elf5 promoter is methylated, low levels of Eomes and/or Cdx2 expression (Fig. 1a) remain inconsequential because the transcriptional loop is interrupted at the level of Elf5. The robust positive-feedback loop created by Elf5 in the TS cell niche allows this compartment to expand in a temporally defined window. Consequently, this cell population is lost and Cdx2 expression cannot be sustained in Elf5 mutants 21 . This compartment can also be established by overexpression of Cdx2 or Eomes in ES cells 31 , which we show is independent of Elf5 demethylation at early stages, but over prolonged periods leads to Elf5 demethylation and expression, thereby maintaining the feedback loop and allowing progression of the trophoblast differentiation pathway ( Supplementary Information, Fig. S4) . Normally, the feedback loop established by Elf5 is temporally restricted to a few cell divisions, positioning Elf5 at the interface between reinforcing trophoblast fate and onset of differentiation. This may be due to the gradual loss of other regulatory factors required for Cdx2 (or Eomes) expression. Consequently, Elf5 can induce trophoblast differentiation from ES cells but unlike Cdx2 cannot convert them into continuously self-renewing TS cell lines. We cannot exclude the possibility that there may be other gatekeeper genes such as Elf5 which are methylated in ES cells and the epiblast. However, our screen was exhaustive and validation studies show that robust methylation differences are detected reliably 32 . In the absence of silencing by DNA methylation, or in a force-expression system, Elf5 has trophoblast-determining functions through its capacity to activate Cdx2 and Eomes. However, within the normal developmental context, Elf5 acts downstream of the trophoblast determinants Cdx2 and Eomes, as well as the recently identified Tead4, which has been shown to induce Cdx2, making it the gene currently at the top of the extra-embryonic fate cascade [33] [34] [35] . A gatekeeper function for such a relatively late-acting gene may at first seem counterintuitive. However, the temporal position of Elf5 in the trophoblast determination cascade correlates perfectly with the developmental fixation of lineage restriction and specifically allows the plasticity and regulation that is characteristic of early mammalian development 3, 36, 37 . Thus, individual blastomeres are still able to cross lineages and expression of lineage 'markers' remains mosaic until the mid-blastocyst stage 19 . Only slightly later, Elf5 expression in the extra-embryonic ectoderm reinforces extra-embryonic cell fate, whereas the inability to activate Elf5 in the epiblast due to promoter methylation restricts its descendants to the embryonic cell fate. The late-acting function of Elf5 is consistent with its position downstream of lineage-determining transcription factors at the interface of stem-cell self-renewal and onset of differentiation.
The extent to which blastomeres of early cleavage-stage mouse embryos are pre-determined towards their future fate has been a matter of some debate 38 . It is now well accepted that position, cell polarization and relative threshold levels of a few interacting transcription factors bias blastomere fate towards the embryonic or extra-embryonic cell lineage 39 . Irreversible fixation of cell fate only occurs at the late blastocyst stage, however, and our findings provide, for the first time, a molecular mechanism for this transition from initial plasticity to lineage-restricted potency in development. This regulative view of development was most famously expressed by C. H. Waddington, who likened the path of a cell lineage towards terminal differentiation to a ball travelling downwards along branching valleys: once it has entered its final valley it cannot easily cross the mountain into the neighbouring one or return to the beginning. This creates canalization of developmental pathways so that they become stable and potentially irreversible 40 . Our observations support a molecular model of regulation and canalization in early mammalian development. Manipulation of gatekeeper genes, such as Elf5, or their epigenetic regulation may help with strategies in regenerative medicine that aim to generate appropriate cell types by transdifferentiation or by reprogramming of somatic cells.
METHODS
Animals and tissue preparation. Mice heterozygous for the Dnmt1
c allele 41 were maintained on a C57BL/6 background. Homozygous null Dnmt1 c/c conceptuses were obtained by heterozygous matings, counting the day of the vaginal plug as E0.5. For histology, E8.5 conceptuses were fixed with 4% paraformaldehyde and processed for routine paraffin histology. For RNA preparation, embryos free of any trophoblast tissues were carefully dissected and snap frozen. -/-cells. For normal growth and expansion, ES cells were grown on gelatin-coated dishes on embryonic feeder-cell layers in standard ES cell medium. For transdifferentiation experiments, 1 × 10 5 cells were plated in gelatin-coated 6-well dishes and grown in standard TS cell conditions (20% fetal bovine serum, 1 mM Na-pyruvate, 50 U ml -1 penicillin, 50 µg ml -1 streptomycin, 50 µM 2-mercaproethanol, 25 ng ml -1 bFGF (Sigma) and 1 µg ml -1 heparin in RPMI1640 (Invitrogen), with 70% of the medium pre-conditioned on embryonic feeder cells 8 ). TS cell differentiation medium consisted of the unconditioned medium without bFGF and heparin. Culture was for the indicated time periods, with medium changes every two days. The TS-GFP line 8 
Aggregation chimaeras and blastocyst outgrowths. For aggregation experiments, Dnmt1
+/+ and Dnmt1 -/-ES cells stably transfected with an H2B-GFP expression vector were cultured for 1-3 days in TS cell medium and then aggregated with 8-cell C57BL/6 embryos. Aggregated embryos were cultured in potassium simplex optimized medium (KSOM) or DMEM containing 10% FBS for 2-3 days. Blastocysts were embedded in fibrin clots and analysed on a Zeiss 510 Meta confocal microscope. The duration of ES-cell preconditioning in TS medium did not affect the rate of TE contribution. Blastocyst outgrowths were obtained by culturing C57BL/6 blastocysts in DMEM with 10% FBS for 3-5 days.
Staining of histological sections and cultured ES cells.
In situ hybridizations on paraffin sections were carried out according to a standard protocol 43 using digoxigenin-labelled riboprobes. For detection of ectopic giant cells, serial sections 42-70 µm apart were hybridized with the pan-trophoblast giant cell marker Plf. Counterstaining was performed with nuclear fast red. For in situ hybridization on cultured cells, ES cells plated on gelatine-coated coverslips were fixed for 20 min with 4% paraformaldehyde and processed using a standard protocol 44 .
Immunostainings were performed after blocking in 0.1% serum and 0.5% BSA for 15 min using the following antibodies and dilutions: anti-Cdx2 (BioGenex) at 1:300-1:400; anti-Eomes (Abcam) 1:200; anti-Elf5 (Santa Cruz Biotechnology) 1:250; anti-Oct3/4 (Santa Cruz Biotechnology) 1:400; anti-Nanog (Abcam) 1:250. Secondary antibodies were Alexa fluorophores from Molecular Probes. Photographs were taken on an Olympus BX41 epifluorescence microscope and a Zeiss 510 Meta confocal microscope.
Quantitative gene expression analysis. Total RNA was isolated from cultured cells or embryos using Trizol reagent and digested with 20 U DNase for 30 min at room temperature. cDNA synthesis was performed with Powerscript reverse transcriptase (BD Biosciences) according to the manufacturer's protocol. cDNAs diluted 1:10 were used for quantitative PCR on an ABI PRISM 7700 Sequence Detector and Stratagene Mx3005P lightcycler using SYBR Green I mastermix (Applied Biosystems) and intron-spanning primer pairs. Ct values were normalized against three housekeeping genes. All samples were analysed at least in triplicate. Methyl-DIP chip. Genomic DNA from ES and TS cells was sheared to an average size of 300-1000 bp and immunoprecipitated with an anti-5-methylcytosine-specific antibody (Eurogentec). The quality of the immunoprecipitation was determined by analysing enrichment of standard genes with known methylation patterns. Immunoprecipitated DNA (4 µg) and sonicated input DNA (3 µg) were hybridized to NimblGen oligonucleotide promoter tiling arrays (2005-03-31_MM5) containing 35,497 mouse promoter fragments. The hybridizations were performed in triplicate with one dye swap using three independent biological samples. The microarray raw data were analysed using the in-house developed software ChipMonk. Microarray data comparison was performed using an empirically determined algorithm 32 where candidate regions containing five or more oligonucleotide probes were filtered to give a CpG proportion of 2-9% and to ensure that the differences were statistically significant (P < 0.01). We confirmed that this algorithm was a robust predictor of methylation state with 88% accuracy (22/25 calls correct).
Sequenom analysis. Two regions were identified as candidates for higher methylation in ES versus TS cells: Elf5 and Sca10. The methylation pattern of these loci was analysed by Sequenom mass array technology (Sequenom). Genomic DNA (1 µg) from ES and TS cells was treated with bisulphite using the Zymo EZ DNA methylation kit (Zymo Research). Promoter regions were selected on the basis of oligonucleotide position on the NimbleGen promoter array, and primer pairs were designed using the MethPrimer program (http://www.urogene.org/methprimer/ index1.html). Amplification of the bisulphite-converted DNA and preparation of the PCR product for quantitative analysis of the promoter methylation detected by the Mass Array system was performed according to the protocol provided by the manufacturer. The number of differentially methylated CpG dinucleotides for these promoters was: 9/10 for Elf5 (methylated CpGs in ES cells: 45.5%; methylated CpGs in TS cells: 5.36%) and 2/3 for Sca10 (ES: 24.33%; TS: 7.67%). We then examined correlation of methylation status with gene expression levels. Sca10 showed equal expression levels in ES and TS cells; thus, the very limited number of differentially methylated CpGs was non-functional and did not affect transcriptional activity. Only Elf5 was expressed at significantly higher levels in TS cells, as predicted from the methylation pattern. Thus, Elf5 was the only differentially methylated gene with functional relevance of the modification in the ES versus TS cell screen.
Bisulphite genomic sequencing. DNA (1 µg) was processed for bisulphite sequencing analysis using the EpiTect Bisulphite kit (Qiagen) according to the manufacturer's protocol. Nested PCR reactions were performed for all genes analysed. Primer sequences are available in the Supplementary Information. PCR products were eluted, sub-cloned and sequenced.
Chromatin immunoprecipitation (ChIP).
Cells from four 92-mm dishes were formaldehyde-crosslinked according to a standard protocol 46 . Chromatin (150 µg) was pre-cleared and incubated with 2 µg goat anti-Elf5 antibody (Santa Cruz Biotechnology) overnight at 4 °C, and then precipitated with Protein G sepharose. Incubation with either goat IgG or with protein G sepharose only was used as a mock control. Bound, unbound and input fractions were analysed using standard and qPCR for Cdx2 and Eomes promoter regions, and normalized against the mock control. ChIP was performed in triplicate from three independent samples. 31 6 days after plating in TS cell medium containing tamoxifen (Tx). The cells clearly adopt trophoblast morphology as shown in the phase contrast image and by expression of trophoblast markers Ascl2 and Pl1 (data are mean ± s.d., *P<0.05, **P<0.005; n=3). Cdx2 is expressed in every cell. Elf5 is not expressed, correlating with the promoter remaining fully methylated as shown by bisulphite sequencing in (e). This demonstrates that initially, trophoblast differentiation mediated by forced expression of Cdx2 is independent of Elf5 and can override the Elf5-dependent feedback loop. Immunofluorescent images were taken at identical settings to positive controls. (e) Elf5 becomes progressively demethylated and activated upon continued force-expression of Cdx2 for 8 and 10 days to allow further progression of the trophoblast differentiation pathway. The promoter region analyzed by bisulphite sequencing is identical to that shown in 
